Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.

doi:10.1021/JM50001A004

Paper

Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.

Published May 1, 1985 · S. Bouhayat, S. Piessard, G. Le Baut

Journal of medicinal chemistry

Q1 SJR score

7

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

N-(4,6-Dimethyl-2-pyridinyl)benzamides 1-24 and the corresponding tertiary derivatives 29-33 were synthesized and studied for possible dopamine-inhibitory properties by testing their effect on motility of naive and reserpinized mice. Unlike the orthopramides, they failed to show any antidopaminergic properties, but some of the secondary derivatives showed instead effects of postsynaptic dopaminergic agonism. The latter compounds were subsequently studied for their effects on apomorphine reversal of reserpine-induced akinesia and on cerebral HVA levels in rats. Contraversive circling induced by compound 11 in 6-hydroxydopamine-lesioned mice suggests that a direct mechanism was involved.

Non-RCT

Animal Study

Study Snapshot

N-(4,6-dimethyl-2-pyridinyl)benzamides show no antidopaminergic properties, but some secondary derivatives show postsynaptic dopaminergic agonism, suggesting a direct mechanism.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.

References

Citations